Monograph Details
|
|
Cardiovascular System
> Hypertension
|
|
PRINZIDE 10-12.5 |
| Manufacturer |
|
Merck & Co., Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
ACE inhibitor + diuretic. |
| Generic Name |
|
Lisinopril 10mg, hydrochlorothiazide 12.5mg; tabs. |
| Also |
• PRINZIDE 20-12.5
• PRINZIDE 20-25
|
| Indications |
|
Hypertension. |
| Children |
|
Not recommended. |
| Adults |
|
Not for initial therapy. Usual maintenance: 1–2 tabs of 20-12.5 or 20-25 once daily, or 1 tab of 10-12.5 once daily. |
| Contraindications |
|
CrCl <30mL/min or serum creatinine >3mg/dL. History of ACEI-associated or other angioedema. Anuria. Sulfonamide hypersensitivity. Pregnancy (Cat.D in 2nd and 3rd trimesters). |
| Precautions |
|
CHF. Coronary or cerebrovascular ischemia. Arrhythmias. Salt/volume depletion. Postsympathectomy. Renal or hepatic impairment. Dialysis (esp. high-flux membrane). Diabetes. Gout. Asthma. Renal artery stenosis. Surgery. Monitor electrolytes, renal function. Monitor WBCs in renal and collagen vascular disease. Discontinue if neutropenia, angioedema or laryngeal edema occurs (SC epinephrine should be available). Pregnancy (Cat.C in 1st trimester). Nursing mothers: not recommended. |
| Interactions |
|
Potentiated by antihypertensives. Potentiates tubocurarine. May antagonize sulfonylureas, oral anticoagulants, uricosurics. May be antagonized by NSAIDs, sympathomimetics. May increase digitalis, lithium, insulin, diazoxide toxicity. Hyperkalemia with K+-sparing diuretics and supplements. Hypokalemia with ACTH, corticosteroids. Orthostatic hypotension may be increased by alcohol, CNS depressants. May interfere with parathyroid, urinary acetone tests. |
| Adverse Reactions |
|
Dizziness, headache, cough, fatigue, orthostatic hypotension, GI disturbances, upper respiratory infection, muscle cramps, asthenia, paresthesia, rash, impotence, electrolyte disturbances (hypokalemia, hyperkalemia, hyponatremia), hyperuricemia. |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|